Core Viewpoint - The company held a half-year performance briefing on October 17, 2025, to provide insights into its operational results and financial status for the first half of 2025, following the release of its semi-annual report on August 26, 2025 [1] Group 1: Performance Overview - The company's revenue decreased while net profit increased due to rising prices of its core product, the pentose series, which improved gross margins [2] - The company strategically reduced the production of alcohol devices with negative gross margins, contributing to the decline in revenue [2] - The company aims to enhance product competitiveness and improve operational performance while adjusting according to market conditions [4] Group 2: Market and Stock Performance - The company acknowledged that stock price fluctuations are influenced by various factors, including macroeconomic conditions, industry cycles, and market sentiment [3] - The company emphasized its compliance with information disclosure regulations and reassured investors that there are no undisclosed material facts [3] Group 3: Future Outlook - The company indicated that its production and operations are currently normal and will continue to focus on its core business [4] - The company will provide updates on its performance trends in future periodic reports and announcements [4] Group 4: Market Position - The company's pentose series products accounted for approximately 25% of the actual production capacity of pentose in the country for the year 2024, according to industry research [6]